MICROSEMI CORPORATION | ||||||||||||||||||||
Schedule Reconciling Selected Non-GAAP Financial Measures | ||||||||||||||||||||
to Comparable GAAP Financial Measures | ||||||||||||||||||||
(unaudited, in millions, except for per share amounts) | ||||||||||||||||||||
| ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarter Ended |
|
Nine Months Ended | ||||||||||||||||
|
|
Jun 29,
|
|
Mar 30,
|
|
Jun 30,
|
|
Jun 29,
|
|
Jun 30,
| ||||||||||
GAAP gross profit |
|
$ |
153.6 |
|
|
$ |
148.6 |
|
|
$ |
138.3 |
|
|
$ |
440.5 |
|
|
$ |
414.4 |
|
Manufacturing profit in acquired inventory (1) |
|
2.2 |
|
|
9.7 |
|
|
— |
|
|
16.7 |
|
|
— |
| |||||
Inventory write-offs from restructuring activities (2) |
|
7.9 |
|
|
— |
|
|
— |
|
|
7.9 |
|
|
— |
| |||||
Non-GAAP gross profit |
|
$ |
163.7 |
|
|
$ |
158.3 |
|
|
$ |
138.3 |
|
|
$ |
465.1 |
|
|
$ |
414.4 |
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||
GAAP operating income |
|
$ |
6.3 |
|
|
$ |
7.3 |
|
|
$ |
25.2 |
|
|
$ |
20.8 |
|
|
$ |
62.6 |
|
Adjustments to GAAP gross profit |
|
10.1 |
|
|
9.7 |
|
|
— |
|
|
24.6 |
|
|
— |
| |||||
Restructuring and other special charges (2) |
|
3.6 |
|
|
6.2 |
|
|
1.5 |
|
|
18.1 |
|
|
9.5 |
| |||||
Facility consolidation and equipment charges |
|
11.2 |
|
|
— |
|
|
— |
|
|
11.2 |
|
|
— |
| |||||
Amortization of intangible assets (3) |
|
23.4 |
|
|
24.3 |
|
|
21.0 |
|
|
69.7 |
|
|
63.9 |
| |||||
Stock based compensation (4) |
|
11.3 |
|
|
11.4 |
|
|
7.1 |
|
|
32.8 |
|
|
25.4 |
| |||||
Acquisition costs (5) |
|
0.3 |
|
|
0.4 |
|
|
— |
|
|
2.4 |
|
|
— |
| |||||
Non-GAAP operating income |
|
$ |
66.2 |
|
|
$ |
59.3 |
|
|
$ |
54.8 |
|
|
$ |
179.6 |
|
|
$ |
161.4 |
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||
GAAP net income (loss) |
|
$ |
(4.3) |
|
|
$ |
(6.8) |
|
|
$ |
18.3 |
|
|
$ |
(9.7) |
|
|
$ |
29.6 |
|
Adjustments to GAAP gross profit and operating income |
|
59.9 |
|
|
52.0 |
|
|
29.6 |
|
|
158.8 |
|
|
98.8 |
| |||||
Loss from facility closure and asset disposal (2) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
0.2 |
| |||||
Credit facility issuance and refinancing costs (6) |
|
0.2 |
|
|
0.9 |
|
|
0.2 |
|
|
1.3 |
|
|
3.8 |
| |||||
(Gain) in debt and derivative instruments (7) |
|
(0.1) |
|
|
(0.1) |
|
|
(0.3) |
|
|
(0.5) |
|
|
(1.0) |
| |||||
Income tax effect on non-GAAP adjustments (8) |
|
(0.9) |
|
|
1.7 |
|
|
(3.0) |
|
|
(4.5) |
|
|
(2.8) |
| |||||
Non-GAAP net income |
|
$ |
54.8 |
|
|
$ |
47.7 |
|
|
$ |
44.8 |
|
|
$ |
145.4 |
|
|
$ |
128.6 |
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||
GAAP diluted earnings (loss) per share |
|
$ |
(0.05) |
|
|
$ |
(0.07) |
|
|
$ |
0.20 |
|
|
$ |
(0.10) |
|
|
$ |
0.33 |
|
Effect of non-GAAP adjustments on diluted earnings per share |
|
$ |
0.63 |
|
|
$ |
0.58 |
|
|
$ |
0.29 |
|
|
$ |
1.64 |
|
|
$ |
1.09 |
|
Non-GAAP diluted earnings per share |
|
$ |
0.58 |
|
|
$ |
0.51 |
|
|
$ |
0.49 |
|
|
$ |
1.54 |
|
|
$ |
1.42 |
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||
Weighted-average diluted shares used in calculating non-GAAP diluted earnings per share |
|
94.8 |
|
|
94.1 |
|
|
91.7 |
|
|
94.2 |
|
|
90.8 |
| |||||
|
|
|
|
|
|
|
|
|
|
| ||||||||||
Operating cash flow |
|
$ |
54.4 |
|
|
$ |
30.2 |
|
|
$ |
52.6 |
|
|
$ |
147.1 |
|
|
$ |
112.6 |
|
Capital expenditures |
|
(8.0) |
|
|
(8.7) |
|
|
(13.6) |
|
|
(28.9) |
|
|
(31.1) |
| |||||
Free cash flow |
|
$ |
46.4 |
|
|
$ |
21.5 |
|
|
$ |
39.0 |
|
|
$ |
118.2 |
|
|
$ |
81.5 |
|
|
Additional details reconciling the selected non-GAAP financial measure to the selected GAAP financial measure may be found in "Notes on Non-GAAP Financial Measures." |